LT3411484T - Viengrandžio arba sau pačiam komplementaraus adeno-asocijuoto viruso 9 injekcija į smegenų skystį - Google Patents
Viengrandžio arba sau pačiam komplementaraus adeno-asocijuoto viruso 9 injekcija į smegenų skystįInfo
- Publication number
- LT3411484T LT3411484T LTEPPCT/US2017/014914T LTUS2017014914T LT3411484T LT 3411484 T LT3411484 T LT 3411484T LT US2017014914 T LTUS2017014914 T LT US2017014914T LT 3411484 T LT3411484 T LT 3411484T
- Authority
- LT
- Lithuania
- Prior art keywords
- stranded
- injection
- self
- cerebrospinal fluid
- associated virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662292157P | 2016-02-05 | 2016-02-05 | |
| PCT/US2017/014914 WO2017136202A1 (en) | 2016-02-05 | 2017-01-25 | Injection of single-stranded or self-complementary adeno-associated virus 9 into the cerebrospinal fluid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3411484T true LT3411484T (lt) | 2023-11-27 |
Family
ID=59500060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/US2017/014914T LT3411484T (lt) | 2016-02-05 | 2017-01-25 | Viengrandžio arba sau pačiam komplementaraus adeno-asocijuoto viruso 9 injekcija į smegenų skystį |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US12070510B2 (lt) |
| EP (2) | EP3411484B1 (lt) |
| JP (4) | JP2019504888A (lt) |
| AU (1) | AU2017214283B2 (lt) |
| DK (1) | DK3411484T3 (lt) |
| ES (1) | ES2962860T3 (lt) |
| FI (1) | FI3411484T3 (lt) |
| HR (1) | HRP20231451T1 (lt) |
| HU (1) | HUE064408T2 (lt) |
| IL (2) | IL300254B2 (lt) |
| LT (1) | LT3411484T (lt) |
| PL (1) | PL3411484T3 (lt) |
| PT (1) | PT3411484T (lt) |
| SI (1) | SI3411484T1 (lt) |
| WO (1) | WO2017136202A1 (lt) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202109219SA (en) | 2009-05-02 | 2021-10-28 | Genzyme Corp | Gene therapy for neurodegenerative disorders |
| CA2912678C (en) | 2013-05-15 | 2023-10-10 | Regents Of The University Of Minnesota | Adeno-associated virus mediated gene transfer to the central nervous system |
| CN112553229A (zh) | 2014-11-05 | 2021-03-26 | 沃雅戈治疗公司 | 用于治疗帕金森病的aadc多核苷酸 |
| RU2020108189A (ru) | 2014-11-14 | 2020-03-11 | Вояджер Терапьютикс, Инк. | Композиции и способы лечения бокового амиотрофического склероза (als) |
| MX2017006217A (es) | 2014-11-14 | 2018-05-02 | Voyager Therapeutics Inc | Polinucleotidos moduladores. |
| EP3230441A4 (en) | 2014-12-12 | 2018-10-03 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scaav |
| GB201508025D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Fabry disease gene therapy |
| LT3411484T (lt) | 2016-02-05 | 2023-11-27 | Emory University | Viengrandžio arba sau pačiam komplementaraus adeno-asocijuoto viruso 9 injekcija į smegenų skystį |
| WO2017181113A1 (en) | 2016-04-15 | 2017-10-19 | The Trustees Of The University Of Pennsyvania | Gene therapy for treating mucopolysaccharidosis type ii |
| AU2017267665C1 (en) | 2016-05-18 | 2023-10-05 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
| WO2018044933A1 (en) | 2016-08-30 | 2018-03-08 | The Regents Of The University Of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
| IL266358B2 (en) | 2016-11-09 | 2025-10-01 | Precigen Inc | Constructs for Prataxin Expression |
| CA3061652A1 (en) | 2017-05-05 | 2018-11-08 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| CN111132626B (zh) | 2017-07-17 | 2024-01-30 | 沃雅戈治疗公司 | 轨迹阵列引导系统 |
| WO2019060662A1 (en) | 2017-09-22 | 2019-03-28 | The Trustees Of The University Of Pennsylvania | GENE THERAPY FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSE TYPE II |
| IL278868B2 (en) | 2017-10-03 | 2025-06-01 | Prevail Therapeutics Inc | Gene therapies for lysosomal disorders |
| WO2019070891A1 (en) | 2017-10-03 | 2019-04-11 | Prevail Therapeutics, Inc. | GENE THERAPIES FOR LYSOSOMAL DISORDERS |
| KR102700963B1 (ko) | 2017-10-03 | 2024-09-02 | 프리베일 테라퓨틱스, 인크. | 리소좀 장애를 위한 유전자 요법 |
| US20190256867A1 (en) | 2018-02-01 | 2019-08-22 | Homology Medicines, Inc. | Adeno-associated virus compositions for restoring pah gene function and methods of use thereof |
| AU2019268330A1 (en) | 2018-05-15 | 2020-11-26 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of Parkinson's disease |
| IL280198B2 (en) * | 2018-07-18 | 2026-01-01 | Regenxbio Inc | Treatment of mucopolysaccharidosis I with fully glycosylated human iduronidase-alpha-L (idus) |
| CN113966399A (zh) | 2018-09-26 | 2022-01-21 | 加州理工学院 | 用于靶向基因疗法的腺相关病毒组合物 |
| EP3856762A1 (en) | 2018-09-28 | 2021-08-04 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
| US20210386870A1 (en) * | 2018-11-26 | 2021-12-16 | Universitat Autònoma De Barcelona | Fibroblast growth factor 21 (FGF21) gene therapy |
| WO2020163299A1 (en) * | 2019-02-04 | 2020-08-13 | Research Institute At Nationwide Children's Hospital | Adeno-associated virus delivery of cln6 polynucleotide |
| CA3133455A1 (en) * | 2019-03-21 | 2020-09-24 | Ptc Therapeutics, Inc. | Vector and method for treating angelman syndrome |
| MX2021012184A (es) | 2019-04-10 | 2022-01-24 | Prevail Therapeutics Inc | Terapias genicas para trastornos lisosomales. |
| US11999974B2 (en) | 2019-04-10 | 2024-06-04 | Prevail Therapeutics, Inc. | Gene therapies for lysosomal disorders |
| JP2022526425A (ja) * | 2019-04-12 | 2022-05-24 | エンコーデッド セラピューティクス， インコーポレイテッド | 治療剤の投与のための組成物および方法 |
| US12398378B2 (en) | 2019-04-12 | 2025-08-26 | University Of Massachusetts | AAV-mediated gene therapy for maple syrup urine disease (MSUD) |
| KR20220128632A (ko) * | 2019-12-31 | 2022-09-21 | 스완바이오 테라퓨틱스 리미티드 | 개선된 aav-abcd1 구축물 및 부신백질이영양증 (ald) 및/또는 부신척수신경병증 (amn)의 치료 또는 예방을 위한 용도 |
| TW202208632A (zh) | 2020-05-27 | 2022-03-01 | 美商同源醫藥公司 | 用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法 |
| EP4171658A4 (en) * | 2020-06-24 | 2025-04-09 | Lycia Therapeutics, Inc. | Modified viral compositions for viral transduction |
| WO2021263060A2 (en) * | 2020-06-24 | 2021-12-30 | Lycia Therapeutics, Inc. | Bifunctional bridging compositions for viral transduction |
| KR20230128001A (ko) * | 2020-12-01 | 2023-09-01 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 엔젤만 증후군의 치료를 위한 조성물 및 이의 용도 |
| EP4284335A1 (en) | 2021-02-01 | 2023-12-06 | RegenxBio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
| JP2024524614A (ja) | 2021-07-14 | 2024-07-05 | ライシア セラピューティクス， インコーポレイテッド | Ａｓｇｐｒ細胞表面受容体結合化合物及びコンジュゲート |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US6110743A (en) | 1995-02-10 | 2000-08-29 | The Regents Of The University Of California | Development and use of human pancreatic cell lines |
| EP0932694A2 (en) | 1996-09-11 | 1999-08-04 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Aav4 vector and uses thereof |
| US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
| DE69939169D1 (de) | 1998-05-28 | 2008-09-04 | Us Gov Health & Human Serv | Aav5 vektoren und deren verwendung |
| PT1127150E (pt) | 1998-11-05 | 2007-08-22 | Univ Pennsylvania | ''sequências de ácido nucleico do vírus adeno associado do serotipo 1, vectores e células hospedeiras que as contêm'' |
| ATE454445T1 (de) | 1998-11-10 | 2010-01-15 | Univ North Carolina | Virusvektoren und verfahren für ihre herstellung und verabreichung. |
| ATE403715T1 (de) | 1999-08-09 | 2008-08-15 | Targeted Genetics Corp | Erhöhung der expression einer einzelsträngigen, heterologen nukleotidsequenz von einem rekombinanten viralen vektor durch ausgestaltung der sequenz in einer art und weise, dass basenpaarungen innerhalb der sequenz entstehen |
| NZ522840A (en) | 2000-06-01 | 2004-12-24 | Univ North Carolina | A parvovirus vector that carries a duplexed genome resulting in co-packaging of strands of plus and minus polarity tethered together |
| US9056048B2 (en) * | 2001-08-16 | 2015-06-16 | The Trustees Of The University Of Pennsylvania | Synthesis and use of cationic steroids for anti-inflammatory drug therapy |
| WO2003045319A2 (en) * | 2001-11-21 | 2003-06-05 | Activbiotics, Inc. | Targeted therapeutics and uses thereof |
| ES2521682T3 (es) | 2003-05-21 | 2014-11-13 | Genzyme Corporation | Procedimientos para producir preparaciones de viriones de AAV recombinantes sustancialmente exentas de cápsidas vacías |
| DK3211085T3 (da) | 2003-09-30 | 2021-06-21 | Univ Pennsylvania | Klader af adeno-associeret virus (aav), sekvenser, vektorer indeholdende disse og anvendelser deraf |
| EP2019143A1 (en) | 2007-07-23 | 2009-01-28 | Genethon | CNS gene delivery using peripheral administration of AAV vectors |
| AU2009209408B2 (en) | 2008-01-29 | 2015-06-11 | Beacon Therapeutics Limited | Recombinant virus production using mammalian cells in suspension |
| US8679837B2 (en) | 2009-04-02 | 2014-03-25 | University Of Florida Research Foundation, Inc. | Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors |
| US8692332B2 (en) | 2010-01-14 | 2014-04-08 | United Microelectronics Corp. | Strained-silicon transistor and method of making the same |
| WO2011094198A1 (en) | 2010-01-28 | 2011-08-04 | The Children's Hospital Of Philadelphia Research Institute, Abramson Research Center | A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
| US10392632B2 (en) | 2011-02-14 | 2019-08-27 | The Children's Hospital Of Philadelphia | AAV8 vector with enhanced functional activity and methods of use thereof |
| WO2013190059A1 (en) * | 2012-06-21 | 2013-12-27 | Association Institut De Myologie | Widespread gene delivery of gene therapy vectors |
| EP2879719B1 (en) * | 2012-08-01 | 2018-07-04 | Nationwide Children's Hospital | Intrathecal delivery of recombinant adeno-associated virus 9 |
| US10821154B2 (en) * | 2013-05-01 | 2020-11-03 | Genzyme Corporation | Compositions and methods for treating spinal muscular atrophy |
| WO2016115503A1 (en) | 2015-01-16 | 2016-07-21 | Voyager Therapeutics, Inc. | Central nervous system targeting polynucleotides |
| LT3411484T (lt) | 2016-02-05 | 2023-11-27 | Emory University | Viengrandžio arba sau pačiam komplementaraus adeno-asocijuoto viruso 9 injekcija į smegenų skystį |
-
2017
- 2017-01-25 LT LTEPPCT/US2017/014914T patent/LT3411484T/lt unknown
- 2017-01-25 HR HRP20231451TT patent/HRP20231451T1/hr unknown
- 2017-01-25 FI FIEP17747935.9T patent/FI3411484T3/fi active
- 2017-01-25 ES ES17747935T patent/ES2962860T3/es active Active
- 2017-01-25 SI SI201731434T patent/SI3411484T1/sl unknown
- 2017-01-25 EP EP17747935.9A patent/EP3411484B1/en active Active
- 2017-01-25 DK DK17747935.9T patent/DK3411484T3/da active
- 2017-01-25 IL IL300254A patent/IL300254B2/en unknown
- 2017-01-25 WO PCT/US2017/014914 patent/WO2017136202A1/en not_active Ceased
- 2017-01-25 EP EP23194145.1A patent/EP4299079A3/en not_active Withdrawn
- 2017-01-25 PL PL17747935.9T patent/PL3411484T3/pl unknown
- 2017-01-25 JP JP2018560432A patent/JP2019504888A/ja not_active Withdrawn
- 2017-01-25 AU AU2017214283A patent/AU2017214283B2/en active Active
- 2017-01-25 PT PT177479359T patent/PT3411484T/pt unknown
- 2017-01-25 HU HUE17747935A patent/HUE064408T2/hu unknown
- 2017-01-25 US US16/075,122 patent/US12070510B2/en active Active
-
2018
- 2018-08-02 IL IL260954A patent/IL260954B2/en unknown
-
2022
- 2022-04-22 JP JP2022070524A patent/JP2022101648A/ja active Pending
-
2023
- 2023-11-07 US US18/504,029 patent/US20240108761A1/en not_active Abandoned
-
2024
- 2024-04-03 JP JP2024059869A patent/JP2024084797A/ja active Pending
- 2024-07-12 US US18/771,234 patent/US20250135041A1/en active Pending
- 2024-12-26 JP JP2024230721A patent/JP2025041933A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3411484B1 (en) | 2023-10-04 |
| IL300254A (en) | 2023-03-01 |
| JP2024084797A (ja) | 2024-06-25 |
| HUE064408T2 (hu) | 2024-03-28 |
| AU2017214283B2 (en) | 2023-06-29 |
| US20190038777A1 (en) | 2019-02-07 |
| IL260954A (lt) | 2018-09-20 |
| ES2962860T3 (es) | 2024-03-21 |
| JP2019504888A (ja) | 2019-02-21 |
| HRP20231451T1 (hr) | 2024-03-01 |
| EP3411484A1 (en) | 2018-12-12 |
| US12070510B2 (en) | 2024-08-27 |
| SI3411484T1 (sl) | 2023-12-29 |
| DK3411484T3 (da) | 2023-11-20 |
| IL300254B2 (en) | 2025-06-01 |
| IL260954B1 (en) | 2023-03-01 |
| IL300254B1 (en) | 2025-02-01 |
| PL3411484T3 (pl) | 2024-02-19 |
| CA3012653A1 (en) | 2017-08-10 |
| JP2025041933A (ja) | 2025-03-26 |
| EP3411484A4 (en) | 2019-08-07 |
| JP2022101648A (ja) | 2022-07-06 |
| IL260954B2 (en) | 2023-07-01 |
| WO2017136202A1 (en) | 2017-08-10 |
| EP4299079A3 (en) | 2024-05-01 |
| EP4299079A2 (en) | 2024-01-03 |
| AU2017214283A1 (en) | 2018-08-02 |
| PT3411484T (pt) | 2023-11-17 |
| FI3411484T3 (fi) | 2023-11-15 |
| US20250135041A1 (en) | 2025-05-01 |
| US20240108761A1 (en) | 2024-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT3411484T (lt) | Viengrandžio arba sau pačiam komplementaraus adeno-asocijuoto viruso 9 injekcija į smegenų skystį | |
| Sanders | The cultural ecology of the Teotihuacan Valley | |
| IL263503A (en) | Variants of a dna polymerase of the polx family | |
| IL276894B (en) | A three-component crispr/cas complex system and uses thereof | |
| IL259253B (en) | Drowsiness onset detection | |
| MA55748A (fr) | Procédés de détection d'aav | |
| IL250016B (en) | Antisense oligonucleotides for the treatment of usher syndrome type 2 | |
| Sarma | Hinduism through the Ages | |
| EP3278099A4 (en) | VALVE MODULE WITH MULTIPLE INJECTION MODE | |
| ITUB20153015A1 (it) | Dispositivo per l'infusione di fluidi | |
| MA43873A (fr) | Dspositif d'injection | |
| EP3322451A4 (en) | ELECTROCHEMICAL REDUCTION OR PREVENTING INFECTIONS | |
| IL252431B (en) | 15-hepe or a composition comprising 15-hepe for treating or preventing fibrosis | |
| EP3365793A4 (en) | AUTHORIZING I / O COMMANDS WITH I / O TOKENS | |
| IL257940A (en) | Vaccine compositions comprising c-c motif chemokine 22 (ccl22) or fragments thereof | |
| EP3482729A4 (en) | Pull-up type absorbent article | |
| ITUA20161865A1 (it) | Uso di lentinano per il trattamento e la prevenzione di endometriosi. | |
| EP3415129A4 (en) | TOTALLY SUCTIONFUL ARTICLE | |
| PL3181778T3 (pl) | Ścienny element okładzinowy, ścienny system okładzinowy, ściana jak również zastosowanie ściennych elementów okładzinowych | |
| FR3037094B1 (fr) | Chassis de dormant et/ou d'ouvrant | |
| EP3363288A4 (en) | COMPOSITION FOR DESTRUCTION OF MICROALGEN OR SPHAEROCARPUS | |
| ITUA20163609A1 (it) | "micro-cogeneratore". | |
| MacKay | The engine of memory | |
| Anantharangachar | The philosophy of Sadhana in Visistadvaita | |
| Velasquez-Manoff | Before the trauma |